Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA‐based therapeutics for asthma
The development of siRNA‐based asthma therapeutics is currently hampered by a paucity of relevant biomarkers and the need to ascertain tissue‐specific gene targeting in the context of active disease. Epithelial STAT6 expression is fundamental to asthma pathogenesis in which inflammatory changes are...
Main Authors: | Healey, G, Evans, N, Hopkin, J, Davies, G, Walker, W |
---|---|
Format: | Journal article |
Published: |
Wiley
2013
|
Similar Items
-
Development of pre-clinical models for evaluating the therapeutic potential of candidate siRNA targeting STAT6.
by: Gareth D Healey, et al.
Published: (2014-01-01) -
59 Preclinical platform for nucleic acid drug evaluation: siRNA and mRNA therapeutics
by: Dong Wang, et al.
Published: (2023-11-01) -
Drug Delivery of siRNA Therapeutics
by: Gaetano Lamberti, et al.
Published: (2020-02-01) -
Engineering siRNA therapeutics: challenges and strategies
by: Syed Saqib Ali Zaidi, et al.
Published: (2023-10-01) -
siRNA a promising tool for diabetes complications
by: Moqbel Ali Moqbel Redhwan, et al.
Published: (2023-09-01)